Generate Biomedicines, Inc. (GENB) Institutional Ownership and Insiders Activity

Generate Biomedicines, Inc. (GENB) is widely held by institutional investors, with 86 firms reporting positions valued at approximately $1.69B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Flagship Pioneering, Llc is the largest disclosed holder, reporting approximately $1.06B in GENB holdings in its latest filing.

Institutional ownership remains highly concentrated, with Flagship Pioneering, Llc representing the majority of disclosed value.